The latest news

First Covid nasal spray vaccine developed by UK scientists enters trials before vaccinating poorest countries

28-Apr-2022

First Covid nasal spray vaccine developed by UK scientists enters trials before vaccinating poorest countries

Unless the majority of the world is vaccinated, new Covid-19 variants will keep emerging, say experts. UK scientists behind a new nasal spray vaccine say it will stifle this as they prepare to distribute it to the world’s poorest countries

Read More
British Biomedical firm, ViraCorp, partners with Incepta to develop innovative nasal COVID-19 vaccine

17-Dec-2021

British Biomedical firm, ViraCorp, partners with Incepta to develop innovative nasal COVID-19 vaccine

ViraCorp has joined forces with leading pharmaceutical company, Incepta, to develop a unique, needle-free COVID-19 vaccine, which uses state-of-the-art intra-nasal technology.

Read More
Lancaster University partnership to develop nasal Covid-19 vaccine

15-Dec-2021

Lancaster University partnership to develop nasal Covid-19 vaccine

Lancaster University has teamed up with biomedical firm ViraCorp to improve vaccination uptake and Covid-19 immunity around the world by developing a one-of-a-kind nasal vaccine.

Read More
ViraCorp partners with Lancaster University to test and develop innovative antiviral technologies

15-Dec-2021

ViraCorp partners with Lancaster University to test and develop innovative antiviral technologies

Lancaster University development of the new vaccine is based on the work of Lancaster molecular virologist Prof. Muhammad Munir, a pioneer of needleless and next-generation COVID-19 vaccine.

Read More
Lancaster University joins forces with British biomedical firm ViraCorp to create ‘vaccine for the world’

14-Dec-2021

Lancaster University joins forces with British biomedical firm ViraCorp to create ‘vaccine for the world’

A new partnership between Lancaster University and biomedical firm ViraCorp has been launched to develop a unique nasal COVID-19 vaccine which attacks the virus at its entry point into the body.

Read More
Intranasal COVID-19 Vaccine Reduces Disease Severity and Blocks Transmission

12-Aug-2021

Intranasal COVID-19 Vaccine Reduces Disease Severity and Blocks Transmission

Lancaster University Scientists have developed a COVID-19 vaccine that can be delivered via a nasal spray.

Read More
Nasal Vaccine Against COVID-19 Works Well In Rodents

12-Aug-2021

Nasal Vaccine Against COVID-19 Works Well In Rodents

Inactivates COVID-19, Influenza and other dangerous respiratory viruses and pathogens.

Read More
Lancaster University team develops new nasal vaccine which could help end COVID-19 pandemic

10-Aug-2021

Lancaster University team develops new nasal vaccine which could help end COVID-19 pandemic

Lancaster University academics today unveiled research on a new nasal vaccine which could block transmission of the COVID-19 virus and transform the international battle against the virus.

Read More
Intranasal vaccine offers promise to block COVID-19 where it starts

10-Aug-2021

Intranasal vaccine offers promise to block COVID-19 where it starts

Research to create a COVID-19 vaccine which can be administered through the nose has taken a significant step forward.

Read More
The Lancaster University Covid vaccine which could be given up your nose

10-Aug-2021

The Lancaster University Covid vaccine which could be given up your nose

University scientists say they are getting close to producing a nasal-spray Covid vaccine.

Read More
Could nasal spray against COVID-19 help solve the pandemic?

02-May-2021

Could nasal spray against COVID-19 help solve the pandemic?

A squirt in the nose — instead of a shot in the arm — to ward off coronavirus.

Read More

Contact Us

Expression of Interest

Contact Form Image